FDA Grants Bavencio® (avelumab) Approval for a Common Type of Advanced Bladder Cancer May 9, 2017October 21, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: PerkinElmer’s SIRION Biotech Teams with Centre for…Danaher Declares pro Rata Dividend of Veralto Common…Roche receives FDA approval for first companion…U.S. FDA grants priority review to Roche’s…FDA grants Priority Review to Roche’s Lunsumio for…FDA grants priority review to Roche’s bispecific…
